Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 41,150 KRW
Change Today -4,050.00 / -8.96%
Volume 535.6K
096530 On Other Exchanges
As of 2:29 AM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for seegene inc (096530)

Although debt as a percent of total capital decreased at Seegene, Inc. over the last fiscal year to 24.45%, it is still in-line with the Biotechnology industry's norm. Additionally, there are enough liquid assets to satisfy current obligations. Cash Collection is a strong suit as the company is more effective than most in the industry. As of the end of 2014, its uncollected receivables totaled 50.1B KRW, which, at the current sales rate provides a Days Receivables Outstanding of 274.45. Last, inventories seem to be well managed as the Inventory Processing Period is typical for the industry, at 218.63 days.
View Balance Sheet In U.S. Dollar
Currency in
Millions of South Korean Wons
As of:Dec 31

Dec 31

Dec 31
Dec 31
4 Year
Cash and Equivalents18,372.64,306.125,961.819,530.6
Short-Term Investments15,936.98,133.79,000.09,086.7
Trading Asset Securities----995.22,513.0
TOTAL CASH AND SHORT TERM INVESTMENTS34,309.612,439.835,957.031,130.4
Accounts Receivable24,351.233,161.546,810.950,051.8
Notes Receivable----873.8--
Other Receivables----961.0520.4
TOTAL RECEIVABLES24,351.233,161.548,645.750,572.2
Prepaid Expenses----102.7318.8
Other Current Assets1,556.72,290.02,056.43,002.5
TOTAL CURRENT ASSETS62,888.152,618.695,604.197,243.4
Gross Property Plant and Equipment----8,865.619,074.5
Accumulated Depreciation-----4,235.0-9,116.6
NET PROPERTY PLANT AND EQUIPMENT2,809.24,479.14,630.69,957.9
Long-Term Investments2,000.02,618.81,609.81,634.0
Accounts Receivable, Long Term4,048.28,971.02,347.7755.4
Loans Receivable, Long Term----1,169.61,457.7
Deferred Tax Assets, Long Term768.81,854.81,662.32,872.7
Deferred Charges, Long Term----14,632.716,400.9
Other Intangibles5,973.613,073.4875.3903.3
Other Long-Term Assets----6,506.95,974.9
TOTAL ASSETS78,487.883,615.6129,039.0138,453.3
Accounts Payable4,534.35,068.64,267.04,122.8
Accrued Expenses----635.9865.9
Short-Term Borrowings----4,000.04,057.9
Current Portion of Long-Term Debt/Capital Lease----3,270.8118.3
Current Income Taxes Payable1,034.42,077.92,284.41,070.1
Other Current Liabilities, Total569.6168.9803.52,219.3
TOTAL CURRENT LIABILITIES6,138.27,315.415,261.712,454.3
Long-Term Debt30,194.031,422.825,312.926,521.0
Minority Interest------84.8
Pension & Other Post-Retirement Benefits1,423.42,827.23,874.44,527.4
Other Non-Current Liabilities--113.0144.8115.7
TOTAL LIABILITIES37,755.541,678.444,593.843,618.4
Common Stock6,536.36,548.18,426.212,652.6
Additional Paid in Capital23,158.023,169.754,142.451,932.4
Retained Earnings10,889.119,516.529,130.138,395.6
Treasury Stock-----8,173.9-8,224.2
Comprehensive Income and Other148.9-7,297.0920.3-6.4
TOTAL COMMON EQUITY40,732.341,937.284,445.294,750.1
TOTAL EQUITY40,732.341,937.284,445.294,834.9
TOTAL LIABILITIES AND EQUITY78,487.883,615.6129,039.0138,453.3

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
096530:KS 41,150.00 KRW -4,050.00

096530 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cepheid $49.34 USD +0.94
GenMark Diagnostics Inc $9.58 USD +0.07
Luminex Corp $18.06 USD +0.05
QIAGEN NV €23.17 EUR -0.67
Sequenom Inc $1.97 USD -0.03
View Industry Companies

Industry Analysis


Industry Average

Valuation 096530 Industry Range
Price/Earnings 100.0x
Price/Sales 16.8x
Price/Book 9.5x
Price/Cash Flow 84.9x
TEV/Sales 16.6x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SEEGENE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at